Skip to main content

Table 5 Overall survival analysis for G-Ki67 in subgroups

From: Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery

 

n

G-Ki67, II vs. I

G-Ki67, III vs. I

HR (95% CI)

P

HR (95% CI)

P

T1

243

1.896 (1.193–3.011)

0.007

4.841 (2.819–8.314)

< 0.001

T2

645

1.299 (1.011–1.670)

0.041

1.714 (1.273–2.310)

< 0.001

T3

294

0.959 (0.682–1.350)

0.811

2.223 (1.451–3.406)

< 0.001

N0

385

1.694 (1.030–2.788)

0.038

2.274 (1.241–4.168)

0.008

N1/2

797

1.247 (1.030–1.510)

0.024

2.267 (1.801–2.855)

< 0.001

T1/2N0 (Stage I)

303

1.866 (1.045–3.334)

0.035

2.333 (1.156–4.705)

0.018

T1/2N1/2

585

1.252 (0.999–1.568)

0.051

2.130 (1.629–2.785)

< 0.001

  1. Abbreviations: CI Confidence interval, HR Hazard ratio, TNM Tumor–node–metastasis